DYNAVAX TECHNOLOGIES CORP — Director's Dealing 2024

Mar 4, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DYNAVAX TECHNOLOGIES CORP (DVAX)
CIK: 0001029142
Period of Report: 2024-03-01

Reporting Person: Burgess Justin (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-03-01	Common Stock	M	4334	$11.12	Acquired	17759	Direct
2024-03-01	Common Stock	M	2767	$9.41	Acquired	20526	Direct
2024-03-01	Common Stock	S	7101	$12.78	Disposed	13425	Direct
2024-03-01	Common Stock	S	13425	$12.78	Disposed	0	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-03-01	Stock Options (Right to Buy)	$11.12	M	4334	Disposed	2030-02-15	Common Stock (0)	Direct
2024-03-01	StockOptions (Right to Buy)	$9.41	M	2767	Disposed	2028-02-02	Common Stock (0)	Direct

Footnotes

F1: Code M - Exercise or conversion of derivative security

F2: Code S - Open market or private sale of non-derivative or derivative security

F3: This transaction was executed in multiple trades at prices ranging from $12.73 to $12.81; the price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which the transactions were effected upon request to the SEC staff, Dynavax, or a security holder of Dynavax.

F4: This option grant will vest over three (3) years with one third (1/3) of the shares subject to the option vesting twelve months after the grant date of February 16, 2023, and one thirty-sixth (1/36) of the shares subject to the option vesting each month thereafter.

F5: This option grant will vest over three (3) years with one third (1/3) of the shares subject to the option vesting twelve months after the grant date of February 3, 2021, and one thirty-sixth (1/36) of the shares subject to the option vesting each month thereafter.